Clinical Trials on Ocular Histoplasmosis Syndrome

Total 39196 results

Synabridge Corporation
Yale University; University of Alabama at Birmingham; University of Tennessee

Unknown

Instrument for Glaucoma Early Detection and Monitoring (IGDM)

Glaucoma

United States
Singapore National Eye Centre

Completed

OculusGen™ Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: a Case-Control Study

Glaucoma
University of Benin

Unknown

Aqueous Mushroom Extract and Intraocular Pressure (AME)

Glaucoma

Nigeria
Sligo General Hospital

Completed

Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification

Ocular Inflammation

Ireland
Shahid Beheshti University of Medical Sciences

Completed

Results of Different Location of Ahmed Glaucoma Valve Implantation in Refractory Glaucoma, Superior Versus Inferior

Glaucoma
University Hospital, Basel, Switzerland

Completed

Assessment of the Ability to Distinguish Odors in Glaucoma Patients

Glaucoma
Robin, Alan L., M.D.
Alcon Research

Unknown

Observational Study of How Patients Take Eye Drops

Glaucoma

United States
University of Parma

Completed

A Comparison Between Deep Sclerectomy and Trabeculectomy

Glaucoma

Italy
Indiana University School of Medicine

Completed

Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C

Glaucoma

United States
University Health Network, Toronto
Merck Frosst Canada Ltd.

Unknown

Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide

Glaucoma

Canada
Innovative Medical

Completed

Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

Glaucoma

United States
University of Parma

Completed

Brimonidine vs ALTP in Progressing Human Glaucoma

Glaucoma

Italy
Federal University of São Paulo

Terminated

INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE

Glaucoma
University Health Network, Toronto

Unknown

The Results of Ahmed Valve Operations

Glaucoma

Canada
Woolsey Pharmaceuticals

Active, not recruiting

Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 (ROCKIT-1)

Progressive Supranuclear Palsy | Corticobasal Syndrome

United States
Laboratorios Sophia S.A de C.V.

Completed

Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV) (087LATAMFIV)

Dry Eye Syndrome

Mexico
National Eye Institute (NEI)

Completed

Potential Research Participants for Future Studies of Inherited Eye Diseases

Glaucoma | Macular Degeneration | Retinitis Pigmentosa | Cataract | Strabismus

United States
Santen Inc.

Completed

Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6

Primary Open-angle Glaucoma and Ocular Hypertension

United States
Aerie Pharmaceuticals

Completed

Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Primary Open Angle Glaucoma or Ocular Hypertension

United States
Ono Pharma USA Inc

Completed

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

Ocular Hypertension (OHT) | Mild Open Angle-glaucoma (OAG)

United States
Groupe Francophone des Myelodysplasies
Bristol-Myers Squibb; AbbVie

Recruiting

Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes

Untreated Myelodysplastic Syndrome

France
Case Comprehensive Cancer Center

Recruiting

CPX-351 Therapy for MDS After Hypomethylating Agent Failure

Myelodysplastic Syndrome (MDS)

United States
Novartis Pharmaceuticals

Completed

A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants (STIMULUS-MDS3)

Myelodysplastic Syndrome (MDS)

France, Spain, Belgium, Italy, Greece, Hungary, Germany
Weill Medical College of Cornell University
Novartis Pharmaceuticals

Completed

MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions (T2*MRI)

Myelodysplastic Syndrome (MDS)

United States
Incyte Corporation

Terminated

Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)

MDS (Myelodysplastic Syndrome)

United States
Chinese Society of Hematology
Harbin Institute of Hematology & Oncology

Unknown

Myelodysplastic Syndrome--CDA-2 Hematological Improvement National Affirmation Study (MD-CHINA)

Myelodysplastic Syndrome (MDS)
Asociación Andaluza de Hematología y Hemoterapia

Completed

Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia (ABRAZA)

Myelodysplastic Syndrome (MDS)

Spain
Genzyme, a Sanofi Company

Terminated

Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome (RISE)

Myelodysplastic Syndrome (MDS)

Germany, United Kingdom, France, Netherlands
Heinrich-Heine University, Duesseldorf

Terminated

Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome (VALENA)

Myelodysplastic Syndrome MDS

Germany
Telik

Terminated

Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
Telik

Completed

Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome (MDS)

United States
Seagen Inc.

Completed

A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndrome (MDS)

United States
Fondazione G.B. Bietti, IRCCS

Recruiting

Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device

Glaucoma

Italy
VividWhite Pty Ltd

Recruiting

VividWhite Glaucoma Implant (VW-51) Pivotal Study

Glaucoma

Australia
University of California, San Francisco

Not yet recruiting

An App-based Instructional Platform to Improve Eye Drop Recall

Glaucoma

United States
University of Maryland, Baltimore
National Eye Institute (NEI); Vasoptic Medical, Inc

Recruiting

Ocular Blood Flow Imaging for Glaucoma Assessment

Glaucoma

United States
Mayo Clinic

Recruiting

Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

Glaucoma

United States
State University of New York at Buffalo
Reichert, Inc.

Recruiting

Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices

Glaucoma

United States
University Hospital Olomouc
Palacky University

Recruiting

Glaucoma Telemedicine Screening (GOLDING)

Glaucoma

Czechia
The University of Hong Kong

Not yet recruiting

Metformin as a Neuroprotective Therapy for Glaucoma - A Randomized Controlled Trial

Glaucoma
Oogziekenhuis Rotterdam

Recruiting

Comparing the Baerveldt and Paul Glaucoma Drainage Devices and Their Effects on the Corneal Endothelium

Glaucoma

Netherlands
University of Maryland, Baltimore

Recruiting

Retinal Blood Flow and Autoregulation

Glaucoma

United States
Brennan Eadie

Not yet recruiting

Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study

Glaucoma

Canada
Germans Trias i Pujol Hospital

Recruiting

Efficacy and Safety of Non-resorbable Uveoscleral Implant Versus Absorbable Collagen Matrix in Non-perforating Deep Sclerectomy

Glaucoma

Spain
Medical University of Graz

Recruiting

Evaluation of Minimal Invasive Glaucoma Surgery

Glaucoma

Austria
State University of New York at Buffalo

Recruiting

Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma (B350vsCP250)

Glaucoma

United States
Cyprus University of Technology

Not yet recruiting

Development and Implementation of an Educational Program to Enhance Adherence to Glaucoma Treatment

Glaucoma

Cyprus
Sensimed AG

Not yet recruiting

Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry

Ocular Hypertension | Glaucoma

Switzerland
Zhongshan Ophthalmic Center, Sun Yat-sen University

Enrolling by invitation

Evaluation of Visual Training System in Patients With Glaucoma

Glaucoma

China
VA Office of Research and Development

Completed

Improve Glaucoma Medication Adherence (MAGIC)

Glaucoma

United States

3

Subscribe